ASK REDCHAT ANYTHING ABOUT COYA THERAPEUTICS INC.
Coya Therapeutics Inc. (NASDAQ: COYA)
Listen to this Section
$5.28
+0.1460
(
+2.85% )
138.9K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| COYA 301 [Low Dose Interleukin-2 (LD IL-2)]DetailsAlzheimer's disease, Neurodegenerative disease |
Phase 2 |
Market Data
|
| Open |
$5.28 |
| Previous Close |
$5.13 |
| Volume |
138.9K |
| Market Cap |
$124.79M |
| Day Range |
$5.10 - $5.39 |
| 52 Week Range |
$3.71 - $7.75 |
| Shares Outstanding |
23.46M |
| Change % |
+2.85% |
| Net Change |
▲ 0.1460 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 2022 |
| Country | United States |
| Underwriter | Chardan Capital Markets, Newbridge Securities, Joseph Gunnar, more |
Insider Ownership Transactions
Total Amount Purchased:
-687,663.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-11-14 |
Buy |
1800.00 |
SNYDER DAVID S |
| 2024-11-13 |
Buy |
5000.00 |
Swaminathan Arun |
| 2024-11-12 |
Buy |
2710.00 |
Grossman Fred |
| 2024-11-12 |
Buy |
5000.00 |
Swaminathan Arun |
| 2024-06-05 |
Sale |
-70596.00 |
Grossman Fred |
| 2024-06-05 |
Sale |
-163663.00 |
Berman Howard |
| 2024-06-05 |
Sale |
-70596.00 |
SNYDER DAVID S |
| 2024-03-05 |
Buy |
1000.00 |
Lee Ann |
| 2024-02-02 |
Sale |
-189680.00 |
Berman Howard |
| 2024-02-02 |
Sale |
-81819.00 |
SNYDER DAVID S |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
56 |
Nov 12, 2025 |
| 8-k |
8K-related |
11 |
Nov 12, 2025 |
| 8-k |
8K-related |
17 |
Oct 27, 2025 |
| 8-k |
8K-related |
12 |
Sep 02, 2025 |
| 4 |
Insider transactions |
1 |
Aug 19, 2025 |
| 10-q |
Quarterly Reports |
55 |
Aug 12, 2025 |
| 8-k |
8K-related |
11 |
Aug 12, 2025 |
| 8-k |
8K-related |
12 |
Jul 29, 2025 |
| 8-k |
8K-related |
12 |
Jul 01, 2025 |
| 8-k |
8K-related |
12 |
Jun 26, 2025 |